KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 57 filers reported holding KALEIDO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $32,300,000 | -31.0% | 19,575,710 | 0.0% | 0.76% | +4.8% |
Q4 2021 | $46,787,000 | -56.2% | 19,575,710 | 0.0% | 0.72% | -35.4% |
Q3 2021 | $106,883,000 | -26.6% | 19,575,710 | 0.0% | 1.12% | -39.8% |
Q2 2021 | $145,643,000 | -8.1% | 19,575,710 | 0.0% | 1.86% | -26.7% |
Q1 2021 | $158,562,000 | -10.0% | 19,575,710 | +1.1% | 2.54% | -20.8% |
Q4 2020 | $176,183,000 | -17.8% | 19,360,710 | 0.0% | 3.21% | -45.8% |
Q3 2020 | $214,323,000 | +49.0% | 19,360,710 | 0.0% | 5.92% | +41.7% |
Q2 2020 | $143,851,000 | +34.7% | 19,360,710 | +11.5% | 4.18% | -16.5% |
Q1 2020 | $106,768,000 | +22.5% | 17,360,710 | 0.0% | 5.00% | +2.7% |
Q4 2019 | $87,151,000 | -33.3% | 17,360,710 | 0.0% | 4.87% | -31.9% |
Q3 2019 | $130,727,000 | -35.1% | 17,360,710 | 0.0% | 7.15% | -18.0% |
Q2 2019 | $201,385,000 | -20.0% | 17,360,710 | 0.0% | 8.72% | -8.5% |
Q1 2019 | $251,731,000 | – | 17,360,710 | – | 9.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 17,360,710 | $106,768,000 | 5.00% |
HARBOURVEST PARTNERS LLC | 1,167,166 | $7,178,000 | 3.46% |
Palo Alto Investors LP | 787,999 | $4,846,000 | 0.41% |
Artal Group S.A. | 500,500 | $3,078,000 | 0.13% |
BAINCO INTERNATIONAL INVESTORS | 22,037 | $136,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $656,000 | 0.02% |
Baillie Gifford | 440,000 | $2,706,000 | 0.00% |
FMR LLC | 2,276,007 | $13,997,000 | 0.00% |
MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 250,372 | $1,540,000 | 0.00% |